Xu Y - Search Results

1

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.

Xu Y, Zheng Y, Sun X, Yu X, Gu J, Wu W, Zhang G, Hu J, Sun W, Mao W. Xu Y, et al. Oncotarget. 2015 Nov 10;6(35):38429-39. doi: 10.18632/oncotarget.5193. Oncotarget. 2015. PMID: 26392415 Free PMC article. Clinical Trial.

2

Induction of p21 by p65 in p53 null cells treated with Doxorubicin.

Ma S, Tang J, Feng J, Xu Y, Yu X, Deng Q, Lu Y. Ma S, et al. Among authors: xu y. Biochim Biophys Acta. 2008 May;1783(5):935-40. doi: 10.1016/j.bbamcr.2008.01.008. Epub 2008 Jan 26. Biochim Biophys Acta. 2008. PMID: 18269916 Free article.

3

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.

Ma S, Xu Y, Deng Q, Yu X. Ma S, et al. Among authors: xu y. Lung Cancer. 2009 Aug;65(2):198-203. doi: 10.1016/j.lungcan.2008.10.028. Epub 2008 Dec 16. Lung Cancer. 2009. PMID: 19091441 Clinical Trial.

4

Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.

Xu Y, Ma S, Ji Y, Sun X, Jiang H, Chen J, Du X, Zheng Y, Qiu G. Xu Y, et al. Lung Cancer. 2011 Jun;72(3):327-32. doi: 10.1016/j.lungcan.2010.09.012. Epub 2010 Nov 5. Lung Cancer. 2011. PMID: 21056507 Clinical Trial.

5

EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.

Xu Y, Zhang Y, Ma S. Xu Y, et al. Lung Cancer. 2011 Sep;73(3):249-55. doi: 10.1016/j.lungcan.2011.04.017. Epub 2011 Jun 8. Lung Cancer. 2011. PMID: 21641672 Review.

6

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

Xu Y, Yu X, Chen Q, Mao W. Xu Y, et al. World J Surg Oncol. 2012 Aug 25;10:173. doi: 10.1186/1477-7819-10-173. World J Surg Oncol. 2012. PMID: 22920951 Free PMC article. Review.

7

The value of endoscopic ultrasonography in defining longitudinal gross target volumes for esophageal squamous carcinoma.

Qiu GQ, Du XH, Yu JP, Zheng YD, Luo HJ, Xu YP, Chen JX, Sun XJ, Ji YL, Tao YL. Qiu GQ, et al. Surg Laparosc Endosc Percutan Tech. 2012 Oct;22(5):424-8. doi: 10.1097/SLE.0b013e31825d393d. Surg Laparosc Endosc Percutan Tech. 2012. PMID: 23047386

8

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.

Xu Y, Sheng L, Mao W. Xu Y, et al. Oncol Lett. 2013 Jan;5(1):19-24. doi: 10.3892/ol.2012.994. Epub 2012 Oct 24. Oncol Lett. 2013. PMID: 23255886 Free PMC article.

9

Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Xu Y, et al. Oncol Lett. 2013 Jan;5(1):185-190. doi: 10.3892/ol.2012.1007. Epub 2012 Oct 30. Oncol Lett. 2013. PMID: 23255917 Free PMC article.

10

Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population.

Xu Y, Jiang Y, Yu X, Chen Q, Zhou X, Mao W. Xu Y, et al. Radiol Oncol. 2013 Mar;47(1):63-70. doi: 10.2478/v10019-012-0039-6. Epub 2013 Feb 1. Radiol Oncol. 2013. PMID: 23450452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,669 results

Search Page

Filters